Is there an increase of blood pressure during intravitreal injections?

March 21, 2019

By Doug Katsev, MD

Article

Check out the latest from the Medical News Minute

Watch Doug Katsev, MD, discuss the latest findings from JAMA Ophthalmology regarding blood pressure and intravitreal injections.

Recent Videos

EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future

$CIME 2024: Neda Shamie, MD, reports on a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussion$

$Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance$

Related Content

Ocugen completes dosing in subjects with GA secondary to dAMD in Phase 1/2 ArMaDa clinical trial of OCU410

Ocugen completes dosing in subjects with GA secondary to dAMD in Phase 1/2 ArMaDa clinical trial of OCU410

Assessing the Evidence for Extending Treatment Intervals in nAMD & DME Management: Expert Insights into Innovative Approaches

Assessing the Evidence for Extending Treatment Intervals in nAMD & DME Management: Expert Insights into Innovative Approaches

Richard Rosen, MD, honored with distinguished award from ASRS

Richard Rosen, MD, honored with distinguished award from ASRS

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Researchers monitor eye microcirculation using multiwavelength laser Doppler holography in time-frequency optical tomography OCT

Researchers monitor eye microcirculation using multiwavelength laser Doppler holography in time-frequency optical tomography OCT

Case Western Reserve University receives $1.5 million grant from Foundation Fighting Blindness to test possible new treatment for inherited retinal disease

Case Western Reserve University receives $1.5 million grant from Foundation Fighting Blindness to test possible new treatment for inherited retinal disease

Related Content

Ocugen completes dosing in subjects with GA secondary to dAMD in Phase 1/2 ArMaDa clinical trial of OCU410

Ocugen completes dosing in subjects with GA secondary to dAMD in Phase 1/2 ArMaDa clinical trial of OCU410

Assessing the Evidence for Extending Treatment Intervals in nAMD & DME Management: Expert Insights into Innovative Approaches

Assessing the Evidence for Extending Treatment Intervals in nAMD & DME Management: Expert Insights into Innovative Approaches

Richard Rosen, MD, honored with distinguished award from ASRS

Richard Rosen, MD, honored with distinguished award from ASRS

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Researchers monitor eye microcirculation using multiwavelength laser Doppler holography in time-frequency optical tomography OCT

Researchers monitor eye microcirculation using multiwavelength laser Doppler holography in time-frequency optical tomography OCT

Case Western Reserve University receives $1.5 million grant from Foundation Fighting Blindness to test possible new treatment for inherited retinal disease

Case Western Reserve University receives $1.5 million grant from Foundation Fighting Blindness to test possible new treatment for inherited retinal disease

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.